sabcs 2011: cleopatra trial, efficacy and safety of pertuzumab, trastuzumab, docetaxel
Published 12 years ago • 1.4K plays • Length 7:24Download video MP4
Download video MP3
Similar videos
-
4:32
cleopatra trial: pertuzumab regimen for frontline her2-positive metastatic breast cancer
-
4:34
paclitaxel with pertuzumab plus trastuzumab in metastatic breast cancer
-
2:40
cleopatra: pertuzumab, trastuzumab & chemo for her2 mbc
-
1:48
dr. baselga discusses the cleopatra pertuzumab trial
-
4:29
pertuzumab, trastuzumab and cyclophosphamide in older patients with her2 breast cancer
-
6:48
pertuzumab adds 16 months survival to trastuzumab plus chemo for her2-positive breast cancer
-
4:44
cleopatra trial
-
9:05
pertuzumab plus trastuzumab and chemotherapy continues to show benefit in her2-positive breast c...
-
6:17
sabcs11 pc josé baselga dual her2 blockade significantly extends progression free survival
-
7:42
results from the aphinity trial of two her2 targeted agents with chemo
-
1:16
dr. perez discusses the cleopatra pertuzumab trial
-
6:13
cleopatra: success with dual her2 blockade in breast cancer
-
1:20
dr. swain discusses the final os analysis from the cleopatra study
-
4:03
aphinity: adding pertuzumab to trastuzumab plus chemotherapy in patients with operable her2-posi...
-
3:16
dual her2 blockade defers breast cancer in cleopatra
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
1:09
trastuzumab emtansine with trastuzumab, pertuzumab, and docetaxel metastatic her2 breast cancer
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer